Washington, WV, United States
Washington, WV, United States

Wheeling Jesuit University is a private, coeducational Roman Catholic university in the United States. Located in Wheeling, West Virginia, it was founded as Wheeling College in 1954 by the Society of Jesus . Today, Wheeling Jesuit University is one of 28 member institutions of the Association of Jesuit Colleges and Universities. Approximately 1,173 undergraduate students attend WJU.Wheeling Jesuit University competes in Division II of the National Collegiate Athletic Association as a member of the Mountain East Conference . Wikipedia.


Time filter

Source Type

News Article | April 17, 2017
Site: www.prweb.com

LearnHowToBecome.org, a leading resource provider for higher education and career information, has released its list of West Virginia’s best colleges for 2017. 17 four-year schools were highlighted, with West Virginia Wesleyan College, Bethany College, Wheeling Jesuit University, West Virginia University Institute of Technology and West Virginia University scoring in the top five. Of the 10 two-year schools included in the ranking, Cabell County Career Technology Center, West Virginia Northern Community College, Blue Ridge Community and Technical College, Mountwest Community and Technical College and Southern West Virginia Community and Technical College were the top five. A full list of winning schools is included below. “These West Virginia schools have created a culture of both academic and career success,” said Wes Ricketts, senior vice president of LearnHowToBecome.org. “When we look at measures of alumni success next to each school’s quality of education, these are the clear leaders in the state.” To be included on West Virginia’s “Best Colleges” list, schools must be regionally accredited, not-for-profit institutions. Each college is also scored on more than a dozen additional data points including diversity of program offerings, career services, educational counseling, financial aid availability, graduation rates and student/teacher ratios. Complete details on each college, their individual scores and the data and methodology used to determine the LearnHowToBecome.org “Best Colleges in West Virginia” list, visit: The Best Four-Year Colleges in West Virginia for 2017 include: Alderson Broaddus University Bethany College Bluefield State College Concord University Davis & Elkins College Fairmont State University Glenville State College Marshall University Ohio Valley University Shepherd University University of Charleston West Liberty University West Virginia State University West Virginia University West Virginia University Institute of Technology West Virginia Wesleyan College Wheeling Jesuit University The Best Two-Year Colleges in West Virginia for 2017 include: Ben Franklin Career Center Blue Ridge Community and Technical College BridgeValley Community & Technical College Cabell County Career Technology Center Eastern West Virginia Community and Technical College Mountwest Community and Technical College New River Community and Technical College Pierpont Community and Technical College Southern West Virginia Community and Technical College West Virginia Northern Community College ### About Us: LearnHowtoBecome.org was founded in 2013 to provide data and expert driven information about employment opportunities and the education needed to land the perfect career. Our materials cover a wide range of professions, industries and degree programs, and are designed for people who want to choose, change or advance their careers. We also provide helpful resources and guides that address social issues, financial aid and other special interest in higher education. Information from LearnHowtoBecome.org has proudly been featured by more than 700 educational institutions.


Wallner K.,Radiation Oncology Service | Sutlief S.,Radiation Oncology Service | Bergsagel C.,Radiation Oncology Service | Merrick G.S.,Wheeling Jesuit University
Radiotherapy and Oncology | Year: 2015

Purpose Some investigators have reported severe rectal complications after brachytherapy. Due to the low number of such events, their relationship to dosimetric parameters has not been well characterized. Methods and materials A total of 3126 patients were treated with low dose rate brachytherapy from 1998 through 2010. 2464 had implant alone, and 313 had implant preceded by 44-46 Gy supplemental external beam radiation (EBRT). Post-implant dosimetry was based on a CT scan obtained on the day of implant, generally within 30 min of the procedure. Every patient's record was reviewed for occurrence of rectal complications. Results Eight of 2464 patients (0.32%) treated with brachytherapy alone developed a radiation-related rectal fistula. Average prostatic and rectal dose parameters were moderately higher for fistula patients than for patients without a severe rectal complication. For instance, the average R100 was 1.2 ± 0.75 cc for fistula patients, versus 0.37 ± 0.88 cc for non-fistula patients. However, the fistula patients' values were well within the range of values for patients without a rectal complication. Four patients had some attempt at repair or reconstruction, but long-term functional outcomes were not favorable. Conclusions Rectal fistulas are a very uncommon potential complication of prostate brachytherapy, which can occur even in the setting of acceptable day 0 rectal doses. Their occurrence is not easily explained by standard dosimetric or clinical factors.


Bittner N.,Tacoma Valley Radiation Oncology Centers | Merrick G.S.,Wheeling Hospital | Butler W.M.,Wheeling Jesuit University | Bennett A.,Wheeling Jesuit University | Galbreath R.W.,Wheeling Jesuit University
Journal of Urology | Year: 2013

Purpose: We determined the incidence of cancer detection by transperineal template guided mapping biopsy of the prostate in patients with at least 1 previously negative transrectal ultrasound guided biopsy. Materials and Methods: From January 2005 to January 2012 at least 1 negative transrectal ultrasound guided biopsy was done in 485 patients in our clinical database before proceeding with transperineal template guided mapping biopsy. No study patient had a previous prostate cancer diagnosis. The incidence of patients with 1, 2, or 3 or greater previous transrectal ultrasound guided biopsies was 55.3%, 25.9% and 18.8%, respectively. Transperineal template guided mapping biopsy was done in 74.8% of patients for increasing or occasionally persistently increased prostate specific antigen, in 19.4% for atypical small acinar proliferation and in 5.8% for high grade prostatic intraepithelial neoplasia. Results: For the entire study population a median of 59 cores was submitted at transperineal template guided mapping biopsy. Cancer was ultimately detected in 226 patients (46.6%) using the transperineal template guided method, including 196 (86.7%) with clinically significant disease according to the Epstein criteria. The most common cancer detection site on transperineal template guided mapping biopsy was the anterior apex. Conclusions: Transperineal template guided mapping biopsy detected clinically significant prostate cancer in a substantial proportion of patients with negative transrectal ultrasound guided biopsy. This technique should be strongly considered in the context of increasing prostate specific antigen with failed confirmation of the tissue diagnosis. © 2013 American Urological Association Education and Research, Inc.


Objective: The objective of this study was to evaluate the effects of regular stretching exercises on pain associated with working at a computer workstation, and to ascertain whether the type of media used for exercise instruction had an effect on outcomes. Participants: Sixty-eight volunteers were divided into three equivalent groups. All of the subjects worked at computers for prolonged periods of time and reported that their pain had been a source of distress for at least three weeks prior to the intake evaluation. Methods: A pretest-posttest-control group design with cluster randomization was used to evaluate the effect of a stretching program on pain. Thirty-six different stretches were performed by the subjects for 15-17 work days. Two intervention groups were directed to stretch once every six minutes. One group (n=22) was reminded to stretch via a computer program, the second group (n=23) by using a hard copy version of the stretches with pictures and written instructions, and a third group received no intervention. Results: ANOVA analysis found a significant reduction in pain of 72% (p < 0.001) for the computer-generated stretching program, and of 64% (p < 0.001) using the hardcopy version of the intervention. The control group had an increase in pain of 1%. Conclusions: Both software and hard copy stretching interventions contributed to a decrease in pain without making any changes to workstation ergonomics and there was no significant statistical difference in the outcomes of either intervention. The subjective evaluation of pain using both visual analog scales and a newly created "pain spot" assessment technique yielded similar results. © 2010 IOS Press and the authors.


Taira A.V.,University of Washington | Merrick G.S.,Wheeling Jesuit University | Galbreath R.W.,Wheeling Jesuit University | Wallner K.E.,University of Washington | Butler W.M.,Wheeling Jesuit University
International Journal of Radiation Oncology Biology Physics | Year: 2010

Purpose: To evaluate the natural history of clinically staged low- and intermediate-risk prostate cancer treated with permanent interstitial seed implants as monotherapy. Methods and Materials: Between April 1995 and May 2005, 463 patients with clinically localized prostate cancer underwent brachytherapy as the sole definitive treatment. Men who received supplemental external beam radiotherapy or androgen deprivation therapy were excluded. Dosimetric implant quality was determined based on the minimum dose that covered 90% of the target volume and the volume of the prostate gland receiving 100% of the prescribed dose. Multiple parameters were evaluated as predictors of treatment outcomes. Results: The 12-year biochemical progression-free survival (bPFS), cause-specific survival, and overall survival rates for the entire cohort were 97.1%, 99.7%, and 75.4%, respectively. Only pretreatment prostate-specific antigen level, percent positive biopsy cores, and minimum dose that covered 90% of the target volume were significant predictors of biochemical recurrence. The bPFS, cause-specific survival, and overall survival rates were 97.4%, 99.6%, and 76.2%, respectively, for low-risk patients and 96.4%, 100%, and 74.0%, respectively, for intermediate-risk patients. The bPFS rate was 98.8% for low-risk patients with high-quality implants versus 92.1% for those with less adequate implants (p < 0.01), and it was 98.3% for intermediate-risk patients with high-quality implants versus 86.4% for those with less adequate implants (p < 0.01). Conclusions: High-quality brachytherapy implants as monotherapy can provide excellent outcomes for men with clinically staged low- and intermediate-risk prostate cancer. For these men, a high-quality implant can achieve results comparable to high-quality surgery in the most favorable pathologically staged patient subgroups. © 2010 Elsevier Inc. All rights reserved.


Taira A.V.,University of Washington | Merrick G.S.,Wheeling Jesuit University | Butler W.M.,Wheeling Jesuit University | Galbreath R.W.,Wheeling Jesuit University | And 3 more authors.
International Journal of Radiation Oncology Biology Physics | Year: 2011

Purpose: To present the largest series of prostate cancer brachytherapy patients treated with modern brachytherapy techniques and postimplant day 0 dosimetric evaluation. Methods and Materials: Between April 1995 and July 2006, 1,656 consecutive patients were treated with permanent interstitial brachytherapy. Risk group stratification was carried out according to the Mt. Sinai guidelines. Median follow-up was 7.0 years. The median day 0 minimum dose covering at least 90% of the target volume was 118.8% of the prescription dose. Cause of death was determined for each deceased patient. Multiple clinical, treatment, and dosimetric parameters were evaluated for impact on the evaluated survival parameters. Results: At 12 years, biochemical progression-free survival (bPFS), cause-specific survival (CSS), and overall survival (OS) for the entire cohort was 95.6%, 98.2%, and 72.6%, respectively. For low-, intermediate-, and high-risk patients, bPFS was 98.6%, 96.5%, and 90.5%; CSS was 99.8%, 99.3%, and 95.2%; and OS was 77.5%, 71.1%, and 69.2%, respectively. For biochemically controlled patients, the median posttreatment prostate-specific antigen (PSA) concentration was 0.02 ng/ml. bPFS was most closely related to percent positive biopsy specimens and risk group, while Gleason score was the strongest predictor of CSS. OS was best predicted by patient age, hypertension, diabetes, and tobacco use. At 12 years, biochemical failure and cause-specific mortality were 1.8% and 0.2%, 5.1% and 2.1%, and 10.4% and 7.1% for Gleason scores 5 to 6 and 7 and ≥8, respectively. Conclusions: Excellent long-term outcomes are achievable with high-quality brachytherapy for low-, intermediate-, and high-risk patients. These results compare favorably to alternative treatment modalities including radical prostatectomy. © 2011 Elsevier Inc.


Raudenbush B.,Wheeling Jesuit University | Capiola A.,Wheeling Jesuit University
Appetite | Year: 2012

Individual differences in human food neophobia (the reluctance to try novel foods) and food neophilia (the overt willingness to try novel foods) influence the evaluation of tastes and odors, as well as the sampling of such stimuli. Past research also notes an association of food neophobia to PTC sensitivity, body weight, and cephalic phase salivary response. The present study assessed physiological reactions of food neophobics and neophilics to pictures of food and non-food stimuli. Stimuli pictures were presented in random order on a computer screen for a period of 5. min. No significant differences were found between the groups in relation to non-food stimuli. However, pulse, GSR, and respirations were significantly increased in food neophobics when presented pictures of food stimuli. Thus, further evidence is provided to support a physiological component at least partially responsible for differences noted between neophobics and neophilics in sensitivity, psychophysical ratings, and "willingness to try" personality. Such a component may also lead to differences in weight, nutrition, and overall health. © 2012 Elsevier Ltd.


Chen C.-H.,National Changhua University of Education | Howard B.,Wheeling Jesuit University
Educational Technology and Society | Year: 2010

This study examined the effect of live simulation on students' science learning and attitude. A total of 311 middle school students participated in the simulation, which allowed them to access and interpret satellite data and images and to design investigations. A pre/post design was employed to compare students' science learning and attitude before and after the simulation. The findings revealed positive changes in students' attitudes and perceptions toward scientists, while male students had more positive adoption toward scientific attitudes than females. The study also found that the change in student's science learning was significantly influenced by the teacher. Hence, teacher classroom preparation for the simulation experience proved vital to students' attitudes toward science as well as their scientific understanding. Implications for effective use of simulation to increase science-related career awareness and inform effective teaching practice are shared and discussed. © International Forum of Educational Technology & Society (IFETS).


Raudenbush B.,Wheeling Jesuit University
American Journal of Rhinology and Allergy | Year: 2011

Background: Several nasal dilator devices designed to stent the anterior nasal airway to increase peak nasal inspiratory flow (PNIF) currently exist; however, comparisons of such devices are limited. This study was designed to compare the efficacy of two different nasal dilator devices, an internal device (Max-Air Nose Cones; Sanostec Corp., Beverly Farms, MA) and an external device (Breathe Right nasal strip; GlaxoSmithKline, Brentford, Middlesex, U.K.) on stenting of the anterior nasal airway to maximize PNIF. Methods: Repeated measurements of PNIF were obtained in 30 individuals noting complaints of sleep-disordered breathing due to nasal breathing discomfort and nasal airway obstruction, both with and without the two different nasal dilator devices. Results: A one-within analysis of variance (ANOVA) was performed among the three conditions (control, Max-Air Nose Cones, and Breathe Right nasal strip), and a statistically significant effect was found (F[2,58] = 298.13; p< 0.00001). Tukey post hoc contrasts revealed that the control condition PNIF (66.07 L/min) was significantly lower than both the Max-Air Nose Cones (138.73 L/min) and the Breathe Right nasal strip (102.17 L/min) conditions. The Max-Air Nose Cone increased inspiratory airflow by 73 L/min, or a 110% improvement over baseline. In addition, the Max-Air Nose Cone condition PNIF was significantly higher than both the control condition and the nasal strip condition. Conclusion: Although both the Max-Air Nose Cones and the Breathe Right nasal strips increased PNIF from baseline, the Max-Air Nose Cones showed significantly greater efficacy at stenting the anterior nasal airway, providing twice the improvement in PNIF over baseline than did the Breathe Right nasal strips. Copyright © 2011, OceanSide Publications, Inc.


Sylvester J.E.,Lakewood Ranch Radiation Oncology | Sylvester J.E.,Prostate Cancer Treatment Center | Grimm P.D.,Lakewood Ranch Radiation Oncology | Wong J.,University of California at Irvine | And 2 more authors.
International Journal of Radiation Oncology Biology Physics | Year: 2011

Purpose: To report 15-year biochemical relapse-free survival (BRFS), cause-specific survival (CSS), and overall survival (OS) outcomes of patients treated with I125 brachytherapy monotherapy for clinically localized prostate cancer early in the Seattle experience. Methods and Materials: Two hundred fifteen patients with clinically localized prostate cancer were consecutively treated from 1988 to 1992 with I125 monotherapy. They were prospectively followed as a tight cohort. They were evaluated for BRFS, CSS, and OS. Multivariate analysis was used to evaluate outcomes by pretreatment clinical prognostic factors. BRFS was analyzed by the Phoenix (nadir + 2 ng/mL) definition. CSS and OS were evaluated by chart review, death certificates, and referring physician follow-up notes. Gleason scoring was performed by general pathologists at a community hospital in Seattle. Time to biochemical failure (BF) was calculated and compared by Kaplan-Meier plots. Results: Fifteen-year BRFS for the entire cohort was 80.4%. BRFS by D'Amico risk group classification cohort analysis was 85.9%, 79.9%, and 62.2% for low, intermediate, and high-risk patients, respectively. Follow-up ranged from 3.6 to 18.4 years; median follow-up was 15.4 years for biochemically free of disease patients. Overall median follow-up was 11.7 years. The median time to BF in those who failed was 5.1 years. CSS was 84%. OS was 37.1%. Average age at time of treatment was 70 years. There was no significant difference in BRFS between low and intermediate risk groups. Conclusion: I125 monotherapy results in excellent 15-year BRFS and CSS, especially when taking into account the era of treatment effect. © 2011 Elsevier Inc.

Loading Wheeling Jesuit University collaborators
Loading Wheeling Jesuit University collaborators